CompoAtlas

MAJ'MELATO

Food supplement declared in France, declaration No 2023-12-613

MAJ'MELATO (MAJELIS) is a food supplement declared in France. Status: retrait du marché annoncé pour le 30 September 2028. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
MAJELIS
Food business operator placing the product on the market
SAS MAJELIS
Status
Retrait du marché annoncé pour le 30 September 2028
Form
Gélule
Daily dose
1 gélule par jour
Directions for use
1 gélule par jour au coucher
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Système nerveux

Declaration 137524, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Other active ingredients

NamePer day
Mélatoninenot declared

Additives

E470b

Other ingredients

maltodextrine, gélatine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

La mélatonine est déconseillée aux personnes souffrant de maladies inflammatoires ou auto-immunes, aux femmes enceintes ou allaitantes, aux personnes devant réaliser une activité nécessitant une vigilance soutenue (risque de somnolence). Un avis médical est conseillé pour : les personnes épileptiques, asthmatiques, souffrant de troubles de l’humeur, du comportement ou de la personnalité. Réservé à l'adulte.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : MAJELIS

Enter to analyse, Shift+Enter for a new line